CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Shares withheld for taxes Chief Accounting Officer gave up 170 shares (to pay taxes)
- 8-K Event Bylaws or fiscal year change
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 6,000,000 shares at $0.50 ($3,000,000)
- 8-K/A Event Shareholder vote results
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 2,704 shares (to pay taxes)
- 4 Planned sale Head of Development sold 431 shares at $269.43 ($116,124)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · New debt or obligation
- SC 13D Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Bylaws or fiscal year change
Page 13 of 137 · 2,721 filings